Items Tagged ‘FOLFOX’

January 15th, 2015

Aggressive Chemotherapy Doubles Survival of Patients with Metastatic Colon Cancer

By

According to the results of a clinical trial presented at the 2015 Gastrointestinal Cancers Symposium in San Francisco, treatment of patients with metastatic colorectal cancer with a four-drug chemotherapy regimen plus Avastin® (bevacizumab) doubles survival when compared to a standard three drug regimen and Avastin. According to estimates from the American Cancer Society, more than […]

View full entry

Tags: avastin, bevacizumab, Colon Cancer, colorectal cancer, crc, folfiri, FOLFOX, News, Stage IV (D)/Relapsed Colon Cancer


June 11th, 2014

FOLFOX Improves Disease-Free Survival in Stage II and III Rectal Cancer Patients

By

Researchers at the University of Ulsan College of Medicine in South Korea reported that treatment with the FOLFOX chemotherapy regimen in rectal cancer patients improved 3-year disease-free survival over a standard chemotherapy of 5-FU/leucovorin. The ADORE study comprised 321 patients with stage II or III rectal cancer who had had their tumors resected (surgically removed). […]

View full entry

Tags: asco, FOLFOX, News, Rectal Cancer, Stages I-III Rectal Cancer